Royal Fund Management’s Thermo Fisher Scientific TMO Stock Holding History

Royal Fund Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,951	Closed	-$2.46M	–	263
2025 Q1	$2.46M	Buy	4,951 +121	+3%	+$60.2K	0.27%	111
2024 Q4	$2.51M	Sell	4,830 -4,210	-47%	-$2.19M	0.23%	113
2024 Q3	$5.59M	Buy	9,040 +4,782	+112%	+$2.96M	0.33%	75
2024 Q2	$2.35M	Buy	4,258 +280	+7%	+$155K	0.19%	102
2024 Q1	$2.31M	Buy	3,978 +240	+6%	+$139K	0.23%	118
2023 Q4	$1.98M	Buy	3,738 +395	+12%	+$210K	0.22%	117
2023 Q3	$1.69M	Buy	3,343 +147	+5%	+$74.4K	0.23%	111
2023 Q2	$1.67M	Buy	3,196 +142	+5%	+$74.1K	0.21%	113
2023 Q1	$1.76M	Buy	3,054 +5	+0.2%	+$2.88K	0.25%	105
2022 Q4	$1.68M	Buy	3,049 +51	+2%	+$28.1K	0.27%	101
2022 Q3	$1.52M	Sell	2,998 -67	-2%	-$34K	0.28%	104
2022 Q2	$1.67M	Sell	3,065 -112	-4%	-$60.8K	0.28%	101
2022 Q1	$1.88M	Buy	3,177 +6	+0.2%	+$3.54K	0.27%	96
2021 Q4	$2.12M	Buy	3,171 +216	+7%	+$144K	0.3%	98
2021 Q3	$1.69M	Buy	2,955 +298	+11%	+$170K	0.25%	104
2021 Q2	$1.34M	Buy	2,657 +369	+16%	+$186K	0.22%	106
2021 Q1	$1.04M	Buy	2,288 +504	+28%	+$230K	0.19%	108
2020 Q4	$830K	Buy	1,784 +359	+25%	+$167K	0.18%	102
2020 Q3	$629K	Buy	1,425 +129	+10%	+$56.9K	0.16%	104
2020 Q2	$469K	Buy	1,296 +140	+12%	+$50.7K	0.17%	107
2020 Q1	$327K	Buy	1,156 +404	+54%	+$114K	0.13%	94
2019 Q4	$244K	Buy	752 +137	+22%	+$44.5K	0.06%	126
2019 Q3	$179K	Buy	615 +118	+24%	+$34.3K	0.05%	144
2019 Q2	$145K	Buy	497 +284	+133%	+$82.9K	0.04%	155
2019 Q1	$58K	Hold	213	–	–	0.02%	198
2018 Q4	$47K	Hold	213	–	–	0.02%	187
2018 Q3	$51K	Sell	213 -13	-6%	-$3.11K	0.02%	188
2018 Q2	$46K	Buy	226 +7	+3%	+$1.43K	0.02%	201
2018 Q1	$45K	Buy	219 +6	+3%	+$1.23K	0.02%	201
2017 Q4	$40K	Buy	213 +13	+7%	+$2.44K	0.01%	224
2017 Q3	$37K	Hold	200	–	–	0.01%	198
2017 Q2	$34K	Hold	200	–	–	0.01%	184
2017 Q1	$30K	Hold	200	–	–	0.01%	185
2016 Q4	$28K	Buy	+200	New	+$28K	0.02%	180